Renu Virmani

Summary

Affiliation: CVPath Institute
Country: USA

Publications

  1. ncbi Ex vivo and preclinical assessment of an endothelial progenitor cell capturing bioengineered stent
    S K Yazdani
    CVPath Institute, Inc, Gaithersburg, MD, USA
    Minerva Cardioangiol 60:11-21. 2012
  2. ncbi Unique demands of the femoral anatomy and pathology and the need for unique interventions
    F Otsuka
    CVPath Institute, Inc, Gaithersburg, MD, USA
    J Cardiovasc Surg (Torino) 54:191-210. 2013
  3. ncbi Effects of intima stiffness and plaque morphology on peak cap stress
    Ali C Akyildiz
    Department of Biomedical Engineering, Thoraxcenter, Erasmus Medical Center, Rotterdam, The Netherlands
    Biomed Eng Online 10:25. 2011
  4. ncbi Atherosclerotic plaque progression and vulnerability to rupture: angiogenesis as a source of intraplaque hemorrhage
    Renu Virmani
    CVPath, International Registry of Pathology, Gaithersburg, MD 20878, USA
    Arterioscler Thromb Vasc Biol 25:2054-61. 2005
  5. ncbi Morphological characteristics of coronary atherosclerosis in diabetes mellitus
    Renu Virmani
    CVPath, International Registry of Pathology, Gaithersburg, Maryland 20878, USA
    Can J Cardiol 22:81B-84B. 2006
  6. ncbi Pathological healing response of explanted MitraClip devices
    Elena Ladich
    Medical Director President, CVPath Institute, Inc, 19 Firstfield Rd, Gaithersburg, MD 20878, USA
    Circulation 123:1418-27. 2011
  7. ncbi Pathology of the vulnerable plaque
    Renu Virmani
    CVPath, International Registry of Pathology, Gaithersburg, Maryland 20878, USA
    J Am Coll Cardiol 47:C13-8. 2006
  8. ncbi Pathology of drug-eluting versus bare-metal stents in saphenous vein bypass graft lesions
    Saami K Yazdani
    CVPath Institute Inc, Gaithersburg, Maryland 20878, USA
    JACC Cardiovasc Interv 5:666-74. 2012
  9. ncbi Delayed arterial healing and increased late stent thrombosis at culprit sites after drug-eluting stent placement for acute myocardial infarction patients: an autopsy study
    Gaku Nakazawa
    CVPath Institute, Inc, 19 Firstfield Rd, Gaithersburg, MD 20878, USA
    Circulation 118:1138-45. 2008
  10. ncbi Ex vivo assessment of vascular response to coronary stents by optical frequency domain imaging
    Masataka Nakano
    CVPath Institute, Gaithersburg, Maryland 20878, USA
    JACC Cardiovasc Imaging 5:71-82. 2012

Detail Information

Publications105 found, 100 shown here

  1. ncbi Ex vivo and preclinical assessment of an endothelial progenitor cell capturing bioengineered stent
    S K Yazdani
    CVPath Institute, Inc, Gaithersburg, MD, USA
    Minerva Cardioangiol 60:11-21. 2012
    ..The focus of this review is to demonstrate the efficacy of the Genous stent in preclinical studies, specifically to show the effectiveness of the anti-CD34+ coating in promoting endothelialization and reducing thrombogenicity...
  2. ncbi Unique demands of the femoral anatomy and pathology and the need for unique interventions
    F Otsuka
    CVPath Institute, Inc, Gaithersburg, MD, USA
    J Cardiovasc Surg (Torino) 54:191-210. 2013
    ..The results from registries support the effectiveness of the atherectomy devices; however, prospective randomized controlled trials are needed to confirm their benefit...
  3. ncbi Effects of intima stiffness and plaque morphology on peak cap stress
    Ali C Akyildiz
    Department of Biomedical Engineering, Thoraxcenter, Erasmus Medical Center, Rotterdam, The Netherlands
    Biomed Eng Online 10:25. 2011
    ..A parametric study was conducted to assess the effect of intima stiffness and plaque morphology on peak cap stress...
  4. ncbi Atherosclerotic plaque progression and vulnerability to rupture: angiogenesis as a source of intraplaque hemorrhage
    Renu Virmani
    CVPath, International Registry of Pathology, Gaithersburg, MD 20878, USA
    Arterioscler Thromb Vasc Biol 25:2054-61. 2005
    ..This review discusses the potential role of intraplaque vasa vasorum in lesion instability as it relates to plaque rupture...
  5. ncbi Morphological characteristics of coronary atherosclerosis in diabetes mellitus
    Renu Virmani
    CVPath, International Registry of Pathology, Gaithersburg, Maryland 20878, USA
    Can J Cardiol 22:81B-84B. 2006
    ..Further studies are needed to better understand the mechanisms that govern greater inflammation and plaque burden in diabetics...
  6. ncbi Pathological healing response of explanted MitraClip devices
    Elena Ladich
    Medical Director President, CVPath Institute, Inc, 19 Firstfield Rd, Gaithersburg, MD 20878, USA
    Circulation 123:1418-27. 2011
    ..The healing response after device implantation has not previously been characterized in humans...
  7. ncbi Pathology of the vulnerable plaque
    Renu Virmani
    CVPath, International Registry of Pathology, Gaithersburg, Maryland 20878, USA
    J Am Coll Cardiol 47:C13-8. 2006
    ..It has only recently been recognized that their identification in living patients might help reduce the incidence of sudden coronary death...
  8. ncbi Pathology of drug-eluting versus bare-metal stents in saphenous vein bypass graft lesions
    Saami K Yazdani
    CVPath Institute Inc, Gaithersburg, Maryland 20878, USA
    JACC Cardiovasc Interv 5:666-74. 2012
    ..The purpose of this study was to assess the pathological responses of atherosclerotic saphenous vein bypass grafts (SVBGs) to drug-eluting stents (DES) versus bare-metal stents (BMS)...
  9. ncbi Delayed arterial healing and increased late stent thrombosis at culprit sites after drug-eluting stent placement for acute myocardial infarction patients: an autopsy study
    Gaku Nakazawa
    CVPath Institute, Inc, 19 Firstfield Rd, Gaithersburg, MD 20878, USA
    Circulation 118:1138-45. 2008
    ..Using autopsy data, we evaluated the pathological responses of the stented segment in patients treated with DES for AMI and compared with patients with stable angina...
  10. ncbi Ex vivo assessment of vascular response to coronary stents by optical frequency domain imaging
    Masataka Nakano
    CVPath Institute, Gaithersburg, Maryland 20878, USA
    JACC Cardiovasc Imaging 5:71-82. 2012
    ..This study sought to examine the capability of optical frequency domain imaging (OFDI) to characterize various morphological and histological responses to stents implanted in human coronary arteries...
  11. ncbi Pioglitazone inhibits in-stent restenosis in atherosclerotic rabbits by targeting transforming growth factor-beta and MCP-1
    Michael Joner
    CVPath Institute Inc, Gaithersburg, MD 20878, USA
    Arterioscler Thromb Vasc Biol 27:182-9. 2007
    ....
  12. ncbi Coronary responses and differential mechanisms of late stent thrombosis attributed to first-generation sirolimus- and paclitaxel-eluting stents
    Gaku Nakazawa
    CVPath Institute, Gaithersburg, Maryland 20878, USA
    J Am Coll Cardiol 57:390-8. 2011
    ..The purpose of this study was to assess the mechanism(s) of late stent thrombosis (LST) and vascular healing responses in first-generation polymeric drug-eluting stents (DES)...
  13. ncbi Vascular responses to drug eluting stents: importance of delayed healing
    Aloke V Finn
    CVPath Institute, Inc, 19 Firstfield, Road, Gaithersburg, MD 20878, USA
    Arterioscler Thromb Vasc Biol 27:1500-10. 2007
    ..Because the time course of complete healing with DES in man is unknown, the optimal duration of antiplatelet treatment remains to be determined...
  14. ncbi Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk
    Michael Joner
    CVPath, International Registry of Pathology, Gaithersburg, Maryland 20878, USA
    J Am Coll Cardiol 48:193-202. 2006
    ..The cause of DES LST is multifactorial with delayed healing in combination with other clinical and procedural risk factors playing a role...
  15. ncbi Elimination of neoangiogenesis for plaque stabilization: is there a role for local drug therapy?
    Frank D Kolodgie
    CVPath Institute, Gaithersburg, Maryland, USA
    J Am Coll Cardiol 49:2093-101. 2007
    ..A multitargeted approach involving selective local antiangiogenic agents should contribute to prevention of plaque progression and its clinical consequences...
  16. ncbi In vitro and in vivo characterisation of biodegradable polymer-based drug-eluting stent
    Saami K Yazdani
    CVPath Institute, Inc, Gaithersburg, MD 20878, USA
    EuroIntervention 7:835-43. 2011
    ..e., biodegradable polymer) coronary drug-eluting stent (DES) (BioMatrix™; Biosensors International, Singapore) to three currently marketed FDA/CE- mark approved non-erodible polymer-coated DES in a porcine model...
  17. ncbi The pathology of neoatherosclerosis in human coronary implants bare-metal and drug-eluting stents
    Gaku Nakazawa
    CVPath Institute, Inc, Gaithersburg, Maryland, USA
    J Am Coll Cardiol 57:1314-22. 2011
    ..Human coronary bare-metal stents (BMS) and drug-eluting stents (DES) from autopsy cases with implant duration >30 days were examined for the presence of neointimal atherosclerotic disease...
  18. ncbi The significance of preclinical evaluation of sirolimus-, paclitaxel-, and zotarolimus-eluting stents
    Gaku Nakazawa
    CVPath Institute Inc, Gaithersburg, Maryland 20878, USA
    Am J Cardiol 100:36M-44M. 2007
    ....
  19. ncbi Atheroma and coronary bifurcations: before and after stenting
    Saami K Yazdani
    CVPath Institute, 19 Firstfield Road, Gaithersburg, MD 20878, USA
    EuroIntervention 6:J24-30. 2010
    ..The occurrence of late stent thrombosis in DES is also shown to be associated with greater presence of uncovered stent struts at the high shear region, which is likely due to local flow mechanics...
  20. ncbi Polymer-free immobilization of a cyclic RGD peptide on a nitinol stent promotes integrin-dependent endothelial coverage of strut surfaces
    Michael Joner
    CVPath Institute, Gaithersburg, Maryland 20878, USA
    J Biomed Mater Res B Appl Biomater 100:637-45. 2012
    ..1 ± 21.9 vs. BSA = 49.9 ± 21.8%, p < 0.03). Immobilization of cRGD peptides on strut surfaces represents an innovative strategy to improve endothelialization, which may facilitate vascular healing after stent implantation...
  21. ncbi Pathobiology of stent thrombosis after drug-eluting stent implantation
    Marc Vorpahl
    CV Path Institute Inc 19 Firstfield Road Gaithersburg, MD, USA
    Curr Pharm Des 16:4064-71. 2010
    ..DES was also associated with premature atherosclerotic changes versus BMS...
  22. ncbi Incidence and predictors of drug-eluting stent fracture in human coronary artery a pathologic analysis
    Gaku Nakazawa
    CVPath Institute, Inc, Gaithersburg, Maryland, USA
    J Am Coll Cardiol 54:1924-31. 2009
    ..The aim of this study was to perform pathologic assessment on stent fracture...
  23. ncbi Drug-eluting stent safety: findings from preclinical studies
    Gaku Nakazawa
    CVPath Institute, Inc, 19 Firstfield Road, Gaithersburg, MD 20850, USA
    Expert Rev Cardiovasc Ther 6:1379-91. 2008
    ....
  24. ncbi Evaluation of polymer-based comparator drug-eluting stents using a rabbit model of iliac artery atherosclerosis
    Gaku Nakazawa
    CVPath Institute Inc, 19 Firstfield Road, Gaithersburg, MD 20878, USA
    Circ Cardiovasc Interv 4:38-46. 2011
    ..Although atherosclerotic models, especially in the rabbit, have existed for a long time, a comparative study of various drug-eluting stent (DES) implantations in atherosclerotic arteries have not been systematically studied...
  25. ncbi Anti-CD34 antibodies immobilized on the surface of sirolimus-eluting stents enhance stent endothelialization
    Gaku Nakazawa
    CVPath Institute, Inc, Gaithersburg, Maryland
    JACC Cardiovasc Interv 3:68-75. 2010
    ..In this study, we hypothesized that an antihuman-CD34 antibody immobilized on the surface of commercially available sirolimus-eluting stents (SES) could enhance re-endothelialization compared with SES alone...
  26. ncbi Histopathologic evaluation of nitinol self-expanding stents in an animal model of advanced atherosclerotic lesions
    Michael Joner
    CVPath Institute, Inc, Gaithersburg, MD 20878, USA
    EuroIntervention 5:737-44. 2010
    ....
  27. ncbi Correlation between carotid intimal/medial thickness and atherosclerosis: a point of view from pathology
    Aloke V Finn
    CVPath Institute Inc, 19 Firstfield Road, Gaithersburg, MD 20878, USA
    Arterioscler Thromb Vasc Biol 30:177-81. 2010
    ..Moreover, in most cases measures of plaque area or volume are generally considered better predictors of an inflammatory process consistent with atherosclerotic disease rather than intimal medial thickness...
  28. ncbi Pathology of atherosclerosis and stenting
    Frank D Kolodgie
    CVPath Institute, Incorporated, 19 Firstfield Road, Gaithersburg, MD 20878, USA
    Neuroimaging Clin N Am 17:285-301, vii. 2007
    ..The histologic features associated with symptomatic and asymptomatic carotid disease are also addressed, along with the issues surrounding current stent-based therapies for the prevention of major recurrent vascular events...
  29. ncbi Lipoprotein-associated phospholipase A2 protein expression in the natural progression of human coronary atherosclerosis
    Frank D Kolodgie
    CVPath Institute Inc, 19 Firstfield Road, Gaithersburg, MD 20878, USA
    Arterioscler Thromb Vasc Biol 26:2523-9. 2006
    ..These findings together with the association of Lp-PLA2 in apoptotic macrophages suggest a potential role in promoting plaque instability...
  30. ncbi The importance of the endothelium in atherothrombosis and coronary stenting
    Fumiyuki Otsuka
    CVPath Institute Inc, 19 Firstfield Road, Gaithersburg, MD 20878, USA
    Nat Rev Cardiol 9:439-53. 2012
    ....
  31. ncbi Free cholesterol in atherosclerotic plaques: where does it come from?
    Frank D Kolodgie
    CVPath Institute, Gaithersburg, Maryland 20878, USA
    Curr Opin Lipidol 18:500-7. 2007
    ..Therefore, intraplaque hemorrhage may not be a passive event, as once considered as studies continue to support the relationship of intraplaque hemorrhage and necrotic core expansion...
  32. ncbi Pathophysiology of vascular healing and stent mediated arterial injury
    Gaku Nakazawa
    CVPath Institute, Inc, Gaithersburg, Maryland, USA
    EuroIntervention 4:C7-10. 2008
    ..Both may lead to late stent thrombosis. Other factors that increase risk are penetration of the necrotic core, bifurcation stenting and malapposition...
  33. ncbi Pathological findings at bifurcation lesions: the impact of flow distribution on atherosclerosis and arterial healing after stent implantation
    Gaku Nakazawa
    CVPath Institute, Inc, Gaithersburg, Maryland 20878, USA
    J Am Coll Cardiol 55:1679-87. 2010
    ....
  34. ncbi Total anomalous origin of the coronary circulation from the right pulmonary artery
    Fabio Tavora
    CVPath Institute, Gaithersburg, MD, USA
    Cardiovasc Pathol 17:246-9. 2008
    ..No other congenital anomalies were identified. Total anomalous origin of the coronary arteries from the pulmonary trunk or artery should be considered in cases of sudden unexpected death in infants...
  35. ncbi Histopathologic assessment of myocardial regeneration
    Naima Carter-Monroe
    CVPath Institute, Gaithersburg, MD, USA
    Methods Mol Biol 660:125-48. 2010
    ..Despite widespread optimism in the success of cell-based therapy, inherent difficulties remain in the identification of effective cell populations proposed for cell-based therapy in the human heart...
  36. ncbi A review of current devices and a look at new technology: drug-eluting stents
    Gaku Nakazawa
    CVPath Institute, Inc, 19 Firstfield Road, Gaithersburg, MD 20878, USA
    Expert Rev Med Devices 6:33-42. 2009
    ..The next-generation DES will probably be safer, with goals of improving endothelialization and more rapid arterial healing compared with first- and second-generation DES...
  37. ncbi Differential response of delayed healing and persistent inflammation at sites of overlapping sirolimus- or paclitaxel-eluting stents
    Aloke V Finn
    CVPath, International Registry of Pathology, Gaithersburg, MD 20878, USA
    Circulation 112:270-8. 2005
    ..Patients receiving overlapping drug-eluting stents need more frequent follow-up than patients with nonoverlapping stents...
  38. ncbi In vitro and in vivo characterization of novel biodegradable polymers for application as drug-eluting stent coatings
    Nathan A Lockwood
    SurModics, Inc, Eden Prairie, MN, USA
    J Biomater Sci Polym Ed 21:529-52. 2010
    ....
  39. ncbi Pathologic Etiologies of Late and Very Late Stent Thrombosis following First-Generation Drug-Eluting Stent Placement
    Fumiyuki Otsuka
    Department of Cardiovascular Pathology, CVPath Institute Inc, 19 Firstfield Road, Gaithersburg, MD 20878, USA
    Thrombosis 2012:608593. 2012
    ....
  40. ncbi Pathology of calcific aortic stenosis
    Elena Ladich
    CVPath, Institute Inc, Gaithersburg, MD 20878, USA
    Future Cardiol 7:629-42. 2011
    ..Various atherosclerotic risk factors have been linked to aortic stenosis and there are mechanistic similarities between atherosclerosis and CAS. The precise pathologic mechanisms underlying aortic stenosis are poorly understood...
  41. ncbi Cardiac inflammatory myofibroblastic tumor: a "benign" neoplasm that may result in syncope, myocardial infarction, and sudden death
    Allen Burke
    CVPath Institute Inc, Gaithersburg, MD 20878, USA
    Am J Surg Pathol 31:1115-22. 2007
    ..These cardiac myofibroblastic tumors are readily distinguished from other endocardial-based cardiac tumors, including papillary fibroelastoma and myxoma, which may present clinically in the same manner...
  42. ncbi The complementary role of microCT and histopathology in characterizing the natural history of stented arteries
    Marc Vorpahl
    CVPath Institute, Inc, 19 Firstfield Road, Gaithersburg, MD 20878, USA
    Expert Rev Cardiovasc Ther 9:939-48. 2011
    ..This article outlines a protocol for ex vivo, postmortem cardiac examination of stented arterial segments with microcomputed tomography followed by histopathologic analysis and highlights the complementary nature of these modalities...
  43. ncbi Vascular pathology of drug-eluting stents
    Gaku Nakazawa
    CVPath Institute, Inc, Gaithersburg, MD 20878, USA
    Herz 32:274-80. 2007
    ..Since the time course of complete healing with DES is unknown, the optimal duration of antiplatelet treatment remains to be determined...
  44. ncbi Pathophysiology of acute myocardial infarction
    Allen P Burke
    CVPath Institute, 19 Firstfield Road, Gaithersburg, MD 20878, USA
    Med Clin North Am 91:553-72; ix. 2007
    ....
  45. ncbi Pathology and vulnerability of atherosclerotic plaque: identification, treatment options, and individual patient differences for prevention of stroke
    Saami K Yazdani
    CVPath Institute, Inc, 19 Firstfield Road, Gaithersburg, MD, 20878, USA
    Curr Treat Options Cardiovasc Med 12:297-314. 2010
    ..Ultimately, however, the identification of important molecular surrogates in early lesion progression may eventually predict late-term risk and likely will provide the ideal strategy for reducing the morbidity and mortality of stroke...
  46. ncbi The bioabsorption process: tissue and cellular mechanisms and outcomes
    Marc Vorpahl
    CVPath, Institute Inc, 19 Firstfield Road, Gaithersburg, MD 20878, USA
    EuroIntervention 5:F28-35. 2009
    ..In short, the future for bio-erodible polymers to treat symptomatic coronary disease is bright with the promise of important and novel therapeutic potential...
  47. ncbi Detection of lipid core coronary plaques in autopsy specimens with a novel catheter-based near-infrared spectroscopy system
    Craig M Gardner
    InfraReDx, Inc, Burlington, Massachusetts 01803, USA
    JACC Cardiovasc Imaging 1:638-48. 2008
    ..This study sought to assess agreement between an intravascular near-infrared spectroscopy (NIRS) system and histology in coronary autopsy specimens...
  48. ncbi Omnipresent atherosclerotic disease: time to depart from analysis of individual vascular beds
    Fumiyuki Otsuka
    CVPath Institute, Gaithersburg, MD, USA
    Mt Sinai J Med 79:641-53. 2012
    ..Therefore, the concept of palliative treatment must be reserved for only those who have progressed beyond preventive measures...
  49. ncbi Histopathology of carotid atherosclerotic disease
    Renu Virmani
    International Registry of Pathology, Inc, Gaithersburg, Maryland, USA
    Neurosurgery 59:S219-27; discussion S3-13. 2006
    ....
  50. ncbi Aortitis and ascending aortic aneurysm: description of 52 cases and proposal of a histologic classification
    Allen P Burke
    CVPath Institute, Gaithersburg, MD 20878, USA
    Hum Pathol 39:514-26. 2008
    ..NNA is less often isolated and best classified as giant cell aortitis. Adult NA has histologic features classically associated with Takayasu disease but is limited primarily to the ascending aorta and has no sex predominance...
  51. ncbi Pediatric heart tumors
    Allen Burke
    CVPath Institute, Gaithersburg, MD 20878, USA
    Cardiovasc Pathol 17:193-8. 2008
    ..Other rare tumors, including histiocytoid cardiomyopathy, hemangioma, germ cell tumors, and sarcomas, may occur in children in the heart and are discussed...
  52. ncbi Sudden cardiac death not related to coronary atherosclerosis
    Elena Ladich
    CVPath, International Registry of Pathology, Inc, Gaithersburg, MD 20878, USA
    Toxicol Pathol 34:52-7. 2006
    ..The important role played by genetics in some of these cardiovascular diseases is presented as well as toxic and drug-related etiologies...
  53. ncbi Cardiovascular pathology in Hutchinson-Gilford progeria: correlation with the vascular pathology of aging
    Michelle Olive
    National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD, USA
    Arterioscler Thromb Vasc Biol 30:2301-9. 2010
    ..We undertook the first histological comparative evaluation between genetically confirmed HGPS and the CVD of aging...
  54. ncbi In vitro evaluation of vascular endothelial and smooth muscle cell survival and apoptosis in response to hypothermia and freezing
    Kristine N Tatsutani
    CryoVascular Systems, Inc, 160 Knowles Drive, Los Gatos, California 95032, USA
    Cryo Letters 26:55-64. 2005
    ..Endovascular cryotherapy designed to induce apoptosis in arterial smooth muscle cells may limit neointimal formation and thereby improve the durability of conventional angioplasty...
  55. ncbi Cardiac tumours: an update: Cardiac tumours
    Allen Burke
    CVPath Institute, Gaithersburg, MD 20878, USA
    Heart 94:117-23. 2008
  56. ncbi Actinomycin-eluting stent for coronary revascularization: a randomized feasibility and safety study: the ACTION trial
    Patrick W Serruys
    Erasmus Medical Center, Rotterdam, The Netherlands
    J Am Coll Cardiol 44:1363-7. 2004
    ..We sought to demonstrate the safety and performance of the actinomycin D-coated Multilink-Tetra stent(Guidant Corp., Santa Clara, California) in the treatment of patients with single de novo native coronary lesions...
  57. ncbi Morphologic findings of coronary atherosclerotic plaques in diabetics: a postmortem study
    Allen P Burke
    Department of Cardiovascular Pathology, Armed Forces Institute of Pathology, Washington, DC 20306-6000, USA
    Arterioscler Thromb Vasc Biol 24:1266-71. 2004
    ..The expression of RAGE and EN-RAGE may further compromise cell survival and promote plaque destabilization...
  58. ncbi Intraplaque hemorrhage and progression of coronary atheroma
    Frank D Kolodgie
    Department of Cardiovascular Pathology, Armed Forces Institute of Pathology, Washington, DC 20306-6000, USA
    N Engl J Med 349:2316-25. 2003
    ..These factors may increase the risk of plaque destabilization...
  59. ncbi Localized hypersensitivity and late coronary thrombosis secondary to a sirolimus-eluting stent: should we be cautious?
    Renu Virmani
    Department of Cardiovascular Pathology, Armed Forces Institute of Pathology, 6825 16th St NW, Washington, DC, USA
    Circulation 109:701-5. 2004
    ..The US Food and Drug Administration recently issued a warning of subacute thrombosis and hypersensitivity reactions to sirolimus-eluting stents (Cypher). The cause and incidence of these events have not been determined...
  60. ncbi From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part II
    Morteza Naghavi
    The Center for Vulnerable Plaque Research, University of Texas Houston, The Texas Heart Institute, and President Bush Center for Cardiovascular Health, Memorial Hermann Hospital, Houston, USA
    Circulation 108:1772-8. 2003
    ..We encourage healthcare policy makers to promote translational research for screening and treatment of vulnerable patients...
  61. ncbi Traditional risk factors and the incidence of sudden coronary death with and without coronary thrombosis in blacks
    Allen P Burke
    Department of Cardiovascular Pathology, Armed Forces Institute of Pathology, Washington, DC 20306-6000, USA
    Circulation 105:419-24. 2002
    ..1) and type 2 diabetes (risk ratio, 2.9). Because these risk factors are associated with SCD in blacks, they may be important targets for reducing the disparately high rate of SCD in blacks as compared with whites...
  62. ncbi Pathology of the unstable plaque
    Renu Virmani
    Department of Cardiovascular Pathology, Armed Forces Institute of Pathology, Washington, DC 20306-6000, USA
    Prog Cardiovasc Dis 44:349-56. 2002
    ..The influence of risk factors for coronary artery disease on culprit lesion morphology is also discussed. Finally, the value of coronary calcification, as a predictor of unstable plaques in the clinical setting, is explored...
  63. ncbi Morphological predictors of restenosis after coronary stenting in humans
    Andrew Farb
    Department of Cardiovascular Pathology, Armed Forces Institute of Pathology, Washington, DC 20306-6000, USA
    Circulation 105:2974-80. 2002
    ..These data suggest the use of stenting strategies that reduce inflammation and neoangiogenesis to reduce the incidence of restenosis...
  64. ncbi Differential accumulation of proteoglycans and hyaluronan in culprit lesions: insights into plaque erosion
    Frank D Kolodgie
    Department of Cardiovascular Pathology, Armed Forces Institute of Pathology, Washington, DC 20306-6000, USA
    Arterioscler Thromb Vasc Biol 22:1642-8. 2002
    ..CONCLUSIONS: Specific accumulation of versican, hyaluronan, and CD44 at the sites of plaque erosion implicates an involvement of these molecules in events associated with acute coronary thrombosis...
  65. ncbi Increased serum homocysteine and sudden death resulting from coronary atherosclerosis with fibrous plaques
    Allen P Burke
    Department of Cardiovascular Pathology, Armed Forces Institute of Pathology, Washington, DC, USA
    Arterioscler Thromb Vasc Biol 22:1936-41. 2002
    ..5 micromol/L). CONCLUSIONS: Increased serum homocysteine is associated with sudden death in the absence of acute coronary thrombosis, especially with concomitant diabetes, and with the presence of lipid-poor, fibrous plaques...
  66. ncbi Mechanism of late in-stent restenosis after implantation of a paclitaxel derivate-eluting polymer stent system in humans
    Renu Virmani
    Catheterization Laboratories, Ospedale San Raffaele and Emo Centro Cuore Columbus, Milan, Italy
    Circulation 106:2649-51. 2002
    ..This study presents the histological findings of atherectomy specimens from a subset of these patients receiving implants...
  67. ncbi Pathology of the thin-cap fibroatheroma: a type of vulnerable plaque
    Renu Virmani
    Department of Cardiovascular Pathology, Armed Forces Institute of Pathology, 6825, 16th Street NW, Washington, DC 20306 6000, USA
    J Interv Cardiol 16:267-72. 2003
    ..Targeted therapy for the purpose of stabilizing coronary lesions that are prone to rupture is a major future goal of the interventionist...
  68. ncbi Pathological mechanisms of fatal late coronary stent thrombosis in humans
    Andrew Farb
    Department of Cardiovascular Pathology, Armed Forces Institute of Pathology, Washington, DC 20306-6000, USA
    Circulation 108:1701-6. 2003
    ..Impaired intimal healing (ie, the failure to form a complete neointimal layer over stent struts) extends the window during which stents are prone to thrombosis...
  69. ncbi Thrombotic thrombocytopenic purpura causing rapid unexpected death: value of CD61 immunohistochemical staining in diagnosis
    Allen P Burke
    Department of Cardiovascular Pathology, Armed Forces Institute of Pathology, Washington, DC 20306-6000, USA
    Cardiovasc Pathol 14:150-5. 2005
    ..Immunohistochemical staining for CD61 and fibrin II is helpful in diagnosing TTP and distinguishing it from DIC...
  70. ncbi Frequency and distribution of thin-cap fibroatheroma and ruptured plaques in human coronary arteries: a pathologic study
    Pavan K Cheruvu
    Harvard Medical School, Boston, Massachusetts, USA
    J Am Coll Cardiol 50:940-9. 2007
    ..Our purpose was to quantify the frequency and distribution of suspected vulnerable lesions, defined as thin-capped fibroatheroma (TCFA) and ruptured plaque, in human coronary artery autopsy specimens...
  71. ncbi Granulocyte-colony stimulating factor administration after myocardial infarction in a porcine ischemia-reperfusion model: functional and pathological effects of dose timing
    Nirat Beohar
    Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA
    Catheter Cardiovasc Interv 69:257-66. 2007
    ..The use of growth factors may prevent this. The aim of this study was to assess early and delayed administration of granulocyte colony-stimulating factor (G-CSF) in a porcine model of myocardial infarction (MI) and reperfusion...
  72. ncbi Antiangiogenic therapy for normalization of atherosclerotic plaque vasculature: a potential strategy for plaque stabilization
    Rakesh K Jain
    Harvard Medical School and Department of Radiation Oncology, Massachusetts General Hospital, Boston, MA 02114, USA
    Nat Clin Pract Cardiovasc Med 4:491-502. 2007
    ..The development of this novel approach to prevent plaque progression might add to the armamentarium of preventive measures for acute myocardial infarction, stroke and sudden cardiac death...
  73. ncbi Diagnosis of thin-cap fibroatheromas by a self-contained intravascular magnetic resonance imaging probe in ex vivo human aortas and in situ coronary arteries
    Jacob Schneiderman
    Department of Vascular Surgery and Gottesdiener Vascular Biology Laboratory, The Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
    J Am Coll Cardiol 45:1961-9. 2005
    ....
  74. ncbi A placebo controlled, dose-ranging, safety study of allogenic mesenchymal stem cells injected by endomyocardial delivery after an acute myocardial infarction
    Seyed M Hashemi
    Cardiovascular Division, Hospital of the University of Pennsylvania, Philadelphia, PA 19104, USA
    Eur Heart J 29:251-9. 2008
    ..Although mesenchymal stem cells (MSCs) show promising signs in reducing myocardial infarct (MI) size, the safety of endomyocardial delivery and the most efficacious dose is unknown...
  75. ncbi Characterization of intimal changes in coronary artery specimens with MR microscopy
    Breno S Pessanha
    Department of Cardiovascular Pathology and Magnetic Resonance Microscopy Facility, Armed Forces Institute of Pathology, Washington, DC, USA
    Radiology 241:107-15. 2006
    ..CONCLUSION: MR microscopy enabled identification of morphologic arterial wall features that enable discrimination of progressive PIT lesions from nonprogressive AIT or IXA lesions...
  76. ncbi Adult cellular rhabdomyoma of the heart: a report of 3 cases
    Allen P Burke
    Department of Cardiovascular Pathology, Armed Forces Institute of Pathology, Washington DC 20306-6000, USA
    Hum Pathol 33:1092-7. 2002
    ..Although surgical excision was possible in all patients, long-term follow-up will be required to determine the true biologic behavior of these neoplasms...
  77. ncbi Morphological predictors of arterial remodeling in coronary atherosclerosis
    Allen P Burke
    Department of Cardiovascular Pathology, Armed Forces Institute of Pathology, Washington, DC, USA
    Circulation 105:297-303. 2002
    ..CONCLUSIONS: Inflammation, calcification, and medial thinning are primary determinants of positive remodeling, which appears to be a feature of plaque instability...
  78. ncbi Adventitial microvessel formation after coronary stenting and the effects of SU11218, a tyrosine kinase inhibitor
    Asim N Cheema
    Roy and Ann Foss Cardiovascular Research Program, Terrence Donnelly Heart Center, St. Michael's Hospital, University of Toronto, Toronto, Ontario, Canada
    J Am Coll Cardiol 47:1067-75. 2006
    ..CONCLUSIONS: Arterial stenting causes arterial wall hypoxia followed by Ad-MV formation. The TKI SU11218 inhibits both Ad-MV formation and IH and represents a promising therapeutic agent to prevent in-stent restenosis...
  79. ncbi Angiographic and histological assessment of successfully treated late acute stent thrombosis secondary to a sirolimus-eluting stent
    Peter Barlis
    Department of Cardiology, Royal Brompton Hospital, Sydney Street, London, UK
    Eur Heart J 28:1675. 2007
  80. ncbi Statin treatment is not associated with consistent alterations in inflammatory status of carotid atherosclerotic plaques: a retrospective study in 378 patients undergoing carotid endarterectomy
    Bart A N Verhoeven
    Department of Vascular Surgery, University Medical Centre Utrecht, Utrecht, The Netherlands
    Stroke 37:2054-60. 2006
    ..04). CONCLUSIONS: Statin use may exert pleiotropic effects on plaque phenotype. However, not the presence of macrophages but activation with subsequent protease and cytokine release may be attenuated by statin use...
  81. ncbi Is pathologic intimal thickening the key to understanding early plaque progression in human atherosclerotic disease?
    Frank D Kolodgie
    Arterioscler Thromb Vasc Biol 27:986-9. 2007
  82. ncbi Impact of intramural thrombus in coronary arteries on the accuracy of tissue characterization by in vivo intravascular ultrasound radiofrequency data analysis
    Kenya Nasu
    Department of Cardiology, Toyohashi Heart Center, Toyohashi, Japan
    Am J Cardiol 101:1079-83. 2008
    ..In conclusion, intramural thrombus was colored as fibrous or fibrofatty by VH IVUS, reducing VH accuracy in these kinds of lesions...
  83. ncbi Pathological correlates of late drug-eluting stent thrombosis: strut coverage as a marker of endothelialization
    Aloke V Finn
    Cardiac Unit, Department of Internal Medicine, Massachusetts General Hospital, Boston, USA
    Circulation 115:2435-41. 2007
    ..Although the clinical predictors of LST have been reported, specific morphological and histological correlates of LST remain unknown...
  84. ncbi Elevated C-reactive protein values and atherosclerosis in sudden coronary death: association with different pathologies
    Allen P Burke
    Department of Cardiovascular Pathology, Armed Forces Institute of Pathology, Washington, DC 20306-6000, USA
    Circulation 105:2019-23. 2002
    ....
  85. ncbi Histopathologic alterations after endovascular radiation and antiproliferative stents: similarities and differences
    Renu Virmani
    Department of Cardiovascular Pathology, Armed Forces Institute of Pathology, Washington, DC, USA
    Herz 27:1-6. 2002
    ..Therefore long-term (24-30 months) angiographic and/or IVUS follow-up studies in man will be required to determine if drug-eluting stents will behave similarly to animal studies at 3 and 6 months...
  86. ncbi Atherosclerotic plaque morphology and coronary thrombi
    Allen P Burke
    Department of Cardiovascular Pathology, Armed Forces Institute of Pathology, Washington, DC 20306-6000, USA
    J Nucl Cardiol 9:95-103. 2002
  87. ncbi Noninvasive imaging of atherosclerotic lesions in apolipoprotein E-deficient and low-density-lipoprotein receptor-deficient mice with annexin A5
    Satoshi Isobe
    Division of Cardiology, University of California, Irvine School of Medicine, 92697, USA
    J Nucl Med 47:1497-505. 2006
    ..CONCLUSION: This study demonstrates the feasibility of noninvasive imaging of atherosclerosis with radiolabeled annexin A5 in transgenic mouse models of human atherosclerosis...
  88. ncbi A hypothesis for vulnerable plaque rupture due to stress-induced debonding around cellular microcalcifications in thin fibrous caps
    Yuliya Vengrenyuk
    Department of Biomedical Engineering, City College of New York, Convent Avenue and 138th Street, New York, NY 10031, USA
    Proc Natl Acad Sci U S A 103:14678-83. 2006
    ..The most likely candidates for the inclusions are either calcified macrophages or smooth muscle cells that have undergone apoptosis...
  89. ncbi Images in cardiovascular medicine. Sirolimus-eluting stent implanted in human coronary artery for 16 months: pathological findings
    Giulio Guagliumi
    Cardiovascular Department, Ospedali Riuniti di Bergamo, Bergamo, Italy
    Circulation 107:1340-1. 2003
  90. ncbi Images in cardiovascular medicine. Myocardial rupture, microvascular obstruction, and infarct expansion: elucidation by cardiac magnetic resonance
    John R Lesser
    Minneapolis Heart Institute Foundation, Minneapolis, MN 55407, USA
    Circulation 108:116-7. 2003
  91. ncbi Embolic protection and platelet inhibition during renal artery stenting
    Christopher J Cooper
    Cardiovascular Division, University of Toledo, 3000 Arlington Ave, MS 1036, Toledo, OH 43614, USA
    Circulation 117:2752-60. 2008
    ..Although atheroembolization can cause renal dysfunction during renal stent procedures, whether adjunctive use of embolic protection devices or glycoprotein IIb/IIIa inhibitors improves renal function is unknown...
  92. ncbi Culprit plaque in myocardial infarction going beyond angiography
    Aloke V Finn
    J Am Coll Cardiol 50:2204-6. 2007
  93. ncbi Decorin promotes aortic smooth muscle cell calcification and colocalizes to calcified regions in human atherosclerotic lesions
    Jens W Fischer
    Molekulare Pharmakologie, , , Germany
    Arterioscler Thromb Vasc Biol 24:2391-6. 2004
    ..CONCLUSIONS: Decorin induces calcification of arterial smooth muscle cell cultures and colocalizes to mineral deposition in human atherosclerotic plaque, suggesting that decorin functions as promoter of intimal calcification...
  94. ncbi Miniature self-contained intravascular magnetic resonance (IVMI) probe for clinical applications
    Aharon Blank
    Topspin Medical Israel, Ltd, Global Park, Lod, Israel
    Magn Reson Med 54:105-12. 2005
    ..The NMR signal can be analyzed to obtain tissue contrast parameters such as T1, T2 and the diffusion coefficient, which may be used to detect lipid-rich vulnerable plaques in the coronary arteries...
  95. ncbi Phenotypic modulation of intima and media smooth muscle cells in fatal cases of coronary artery lesion
    Hiroyuki Hao
    Department of Pathology and Immunology, University of Geneva-CMU, Geneva, Switzerland
    Arterioscler Thromb Vasc Biol 26:326-32. 2006
    ..The high accumulation of alpha-SMA-positive MFs in erosions compared with stable plaques correlates with the higher appearance of thrombotic complications in this situation...
  96. ncbi The accumulation of specific types of proteoglycans in eroded plaques: a role in coronary thrombosis in the absence of rupture
    Frank D Kolodgie
    Department of Cardiovascular Pathology, Armed Forces Institute of Pathology, Washington, DC 20306-6000, USA
    Curr Opin Lipidol 15:575-82. 2004
    ..The development of relevant animal models should allow further insight into the pathophysiology of coronary thrombosis in the absence of rupture...
  97. ncbi Terminology for high-risk and vulnerable coronary artery plaques. Report of a meeting on the vulnerable plaque, June 17 and 18, 2003, Santorini, Greece
    Johannes A Schaar
    Department of Experimental Echocardiography, Erasmus Medical Center Rotterdam, Dr Molewaterplein 50, P O Box, 1738 Room Ee 23 32, 3000 DR Rotterdam, The Netherlands
    Eur Heart J 25:1077-82. 2004
    ..It is the hope that this usage might be of value to the larger community of scientists working in this field, and that widespread adoption of a common nomenclature would accelerate progress in the prevention of acute coronary events...
  98. ncbi Women's Ischemic Syndrome Evaluation: current status and future research directions: report of the National Heart, Lung and Blood Institute workshop: October 2-4, 2002: Section 3: diagnosis and treatment of acute cardiac ischemia: gender issues
    Elizabeth G Nabel
    Circulation 109:e50-2. 2004
  99. ncbi Preclinical restenosis models and drug-eluting stents: still important, still much to learn
    Robert S Schwartz
    Minneapolis Heart Institute, Minneapolis, Minnesota 55407, USA
    J Am Coll Cardiol 44:1373-85. 2004
    ..Ongoing research into animal models will reconcile apparent differences with clinical trials and advance our understanding of how to apply animal models to clinical stenting in the era of DESs...
  100. ncbi Short-term intravenous eptifibatide infusion combined with reduced dose recombinant tissue plasminogen activator inhibits platelet recruitment at sites of coronary artery injury
    Mark H Rubenstein
    Cardiac Unit and the Department of Pathology, Massachusetts General Hospital, Boston, Massachusetts 02114, USA
    J Am Coll Cardiol 43:287-94. 2004
    ..CONCLUSIONS: Short-term infusion Ep plus low-dose rt-PA acutely neutralizes the ability of damaged endothelial surfaces to recruit new platelets by inhibiting platelet aggregation and eliminating residual mural thrombus...
  101. ncbi Multislice computed tomographic characteristics of coronary lesions in acute coronary syndromes
    Sadako Motoyama
    Department of Cardiology, Fujita Health University, Toyoake, Japan
    J Am Coll Cardiol 50:319-26. 2007
    ..To evaluate the feasibility of noninvasive assessment of the characteristics of disrupted atherosclerotic plaques, the authors interrogated the culprit lesions in acute coronary syndromes (ACS) by multislice computed tomography (CT)...